Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 4
2017 8
2018 3
2019 4
2020 4
2021 2
2022 4
2023 9
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.
Huguet F, Guerci-Bresler A, Roth-Guepin G, Cayssials E, Slama B, Santagostino A, Penot A, Quittet P, Cony-Makhoul P, Saad A, Bastie JN, Hacini M, Coiteux V, Uzunov M, Roy L, Le Clech L, Berger M, Agneray AM, Messas E, Etienne G, Turhan A, Nicolini FE, Rousselot P. Huguet F, et al. Among authors: cayssials e. Br J Haematol. 2024 Dec;205(6):2295-2304. doi: 10.1111/bjh.19819. Epub 2024 Nov 6. Br J Haematol. 2024. PMID: 39506529 Free PMC article.
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.
Luque Paz D, Gagelmann N, Benajiba L, Riou J, Salit R, Orvain C, Schroeder T, Bories C, Gurnari C, Badbaran A, Boyer F, Pagliuca S, Rautenberg C, Tavitian S, Pangiota V, Ianotto JC, Thol F, Cayssials E, Heuser M, Rubio MT, Cassinat B, Daltro de Oliveira R, Sauter C, Maciejewski JP, Reinhardt HC, Scott BL, Ugo V, Kröger N, Kiladjian JJ, Robin M. Luque Paz D, et al. Among authors: cayssials e. Blood Adv. 2025 Feb 25;9(4):797-807. doi: 10.1182/bloodadvances.2024014368. Blood Adv. 2025. PMID: 39561372 Free PMC article.
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort.
Lefèvre G, Bleuse S, Puyade M, Moulis G, Néel A, Abisror N, Baudet A, Bonnotte B, Dion J, Dossier A, Grall M, Lifermann F, Limal N, Lioger B, Machelart I, Mohr C, Outh R, Queyrel-Moranne V, Slama B, Tréfond L, Abou Chahla W, Ackerman F, Belfeki N, Berezne A, Blade JS, Bouderbala MA, Chebrek S, Cottin V, De Almeida S, De Masson A, Dezoteux F, Goulenok T, Jachiet V, Jouvray M, Latu I, Ledoult E, Leurs A, Lugosi M, Martin M, Melboucy-Belkhir S, Morati-Hafsaoui C, Quemeneur T, Rohmer J, Roy-Peaud F, Sanges S, Schleinitz N, Staumont-Salle D, Taillé C, Terriou L, Tieulie N, Koenga JDE, Schwarb L, Panel K, Kahn JE, Groh M; COHESion study group. Lefèvre G, et al. Allergy. 2025 Apr;80(4):1100-1110. doi: 10.1111/all.16463. Epub 2025 Jan 5. Allergy. 2025. PMID: 39757773
Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome.
Stammler R, Vallée A, Rohmer J, Grardel N, Abisror N, Chahla WA, Ackermann F, Baudet A, Belfeki N, Ben Abdelali R, Bidet A, Bladé JS, Bleuse S, Bonnotte B, Bouderbala MA, Cayuela JM, Chebrek S, Dion J, Dossier A, Duployez N, Faguer S, Flandrin-Gresta P, Galicier L, Godon C, Grall M, Jachiet V, Jouvray M, Latu I, Ledoult E, Lengline E, Leurs A, Lhermitte L, Lifermann F, Limal N, Lioger B, Lugosi M, Machelart I, Martin M, Martis N, Mauvieux L, Melboucy-Belkhir S, Mohr C, Moulis G, Mozicconacci MJ, Naguib D, Néel A, Nicolini FE, Outh R, Panel K, Preudhomme C, Puyade M, Quemeneur T, Queyrel Moranne V, Rey J, Rousselot P, Schleinitz N, Slama B, Staumont-Salle D, Taillé C, Terriou L, Tréfond L, Viallard JF, Kahn JE, Lefèvre G, Groh M; COHESion, CEREO and GBMHM groups. Stammler R, et al. J Allergy Clin Immunol Pract. 2025 Sep 22:S2213-2198(25)00903-1. doi: 10.1016/j.jaip.2025.09.009. Online ahead of print. J Allergy Clin Immunol Pract. 2025. PMID: 40992688
The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy.
Decroos A, Meddour S, Demoy M, Piccirilli N, Rousselot P, Nicolini FE, Ragot S, Gombert JM, Herbelin A, Barbarin A, Cayssials E. Decroos A, et al. Among authors: cayssials e. Front Immunol. 2024 Nov 15;15:1473139. doi: 10.3389/fimmu.2024.1473139. eCollection 2024. Front Immunol. 2024. PMID: 39620210 Free PMC article.
Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMC.
Johnson-Ansah H, Charbonnier A, Etienne G, Roy L, Legros L, Roth-Guépin G, Orvain C, Bouvier A, Cayssials E, Coiteux V, Rousselot P, Naguib D, Damaj G, Lebon D, Mahon FX, Flandrin-Gresta P, Dulucq S, Hayette S, Cayuela JM, Nicolini FE, Rea D. Johnson-Ansah H, et al. Among authors: cayssials e. Leuk Res. 2025 Jul;154:107716. doi: 10.1016/j.leukres.2025.107716. Epub 2025 May 14. Leuk Res. 2025. PMID: 40398342
42 results